Financial Health of Biotechnology and Drugs Industry in India and China

Share this:
     
Published: 20 Dec 2010

The research services examines the financial performance of Indian and Chinese biotechnology companies across 2 broad parameters- Excellence in financial management and Excellence in risk management. The companies are analysed using over 50 financial ratios and other parameters and are grouped under these 2 categories. Each ratio has a weight assigned to obtain the final score. A weighted average score which is the sum product of the ratios and the weights thereof, was used to rank the companies in the biotechnology segment. The ratios are then grouped into financial and risk management and we gave a comprehensive ranking based on the scores under both the heads.

  1.  
  2.  
  3.  
  4.  
  5.  

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..